Hainan Poly Pharm Co (SZSE:300630) Total Stockholders Equity : ¥3,142 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Total Stockholders Equity?

Hainan Poly Pharm Co's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ¥3,142 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hainan Poly Pharm Co's Book Value per Share for the quarter that ended in Sep. 2023 was ¥7.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hainan Poly Pharm Co's Debt-to-Equity for the quarter that ended in Sep. 2023 was 0.84.

Hainan Poly Pharm Co Total Stockholders Equity Historical Data

The historical data trend for Hainan Poly Pharm Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Total Stockholders Equity Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

883.26

1,145.94

2,039.15

2,541.76

2,802.51

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															2,867.01	2,802.51	2,940.50	3,013.13	3,142.39

Hainan Poly Pharm Co (SZSE:300630) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hainan Poly Pharm Co's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3142.393	-	0)	/	449.039
	=	7.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hainan Poly Pharm Co's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(727.588	+	1903.077)	/	3142.393
	=	0.84

Hainan Poly Pharm Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines